Two Cases of Pancreatic Cancer Treatment with CARsgen’s CT041 Published in Journal of Hematology & Oncology
SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced the publication of two cases of the treatment of metastatic pancreatic cancer with CARsgen's CT041, an innovative Claudin (CLDN) 18.2 CAR...
Latest Sports & Fitness Innovation: Holistic Training Syllabus by MAVERICKS Life Co.
CRANS-MONTANA, Switzerland, Sept. 21, 2023 /PRNewswire/ -- Sports science & wellbeing education company, MAVERICKS Life Co., announces the release of its new Holistic Training Syllabus, rooted in evolutionary biology and epigenetics theory. It's a brand new innovation in the sports and fitness sector. Recent scientific studies* have led...
Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023
SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will participate in the Vitafoods Asia 2023 event in Bangkok, Thailand with the goal of entering the global market. Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023 Yuyu Healthcare will operate a booth at the event and focus on promoting its ODM...
ADM Joins GAR and Tzu Chi Indonesia to Accelerate Progress in Indonesia’s Rural Economies
ADM partners with Golden Agri-Resources (GAR) and Tzu Chi Indonesia to expand the reach of rural development initiatives. The programme will enhance access to childcare and promote sustainable rural entrepreneurship in Indonesia's Riau province. JAKARTA, Indonesia, Sept. 21, 2023 /PRNewswire/ -- Three regencies in Indonesia's Riau province will benefit from...
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB
HANGZHOU, China, Sept. 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, today announced the successful completion of Series C2 financing. This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperity Investment, Haibang Venture and...
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets
SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today it has entered into a collaboration and license agreement with Kezar Life Sciences ("Kezar"), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune mediated and oncologic disorders,...
Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”
MILAN, Sept. 21, 2023 /PRNewswire/ -- Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence is the title describing the theme of the 2023 edition of Bracco Innovation Day. This event took place at the Human Technopole Auditorium...
European Commission Approves Menarini Group’s ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients in Europe die annually from the disease² ORSERDU is the first treatment specifically for patients with ER+, HER2- advanced or metastatic breast cancer tumors...
Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist
HONG KONG and NANJING, China, Sept. 20, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical-stage biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for its HPG7233, an agonist of Thyroid Hormone Receptor beta (THR-β) for the treatment of patients with non-alcoholic steatohepatitis (NASH) and dyslipidemia. HPG7233...
Taiwan’s Premier Health Brand Unveils Best Quality Pineapple Enzyme for Digestive Health
NISORO HEALTH introduces high-quality Pineapple Enzyme, a digestive elixir blending Taiwan's pineapples and LJ88 probiotics. It enhances digestion, promotes gut health, and is suitable for all ages. TAIPEI, Sept. 20, 2023 /PRNewswire/ -- Taiwan is renowned for its exceptional products, and NISORO proudly introduces Pineapple Enzyme, an extraordinary fusion of pineapple fruit and probiotic fermentation. Pineapple Enzyme is a...
